Literature DB >> 30614092

On-site identification of psychoactive drugs by portable Raman spectroscopy during drug-checking service in electronic music events.

Enrico Gerace1, Fabrizio Seganti1, Clemente Luciano1, Tonia Lombardo1, Daniele Di Corcia1, Heino Teifel2, Marco Vincenti1,3, Alberto Salomone1,3.   

Abstract

INTRODUCTION AND AIMS: Hundreds of new psychoactive substances (NPS) have burst into the marketplace, making both the scientific community and people who use drugs lacking of adequate information about their diffusion and effects. In this scenario, drug-checking services have been recently proposed to assist harm reduction policies and provide a global description of the circulating drugs. DESIGN AND METHODS: The results obtained by a portable Raman spectroscopy device on 472 alleged drugs within the first formal implementation of drug checking in Italy, are reported. The testing was made through a plastic bag held by the applicant and containing the alleged drug. The substance identification was executed by comparison with a spectral library.
RESULTS: Illicit substances were detected in 304 samples. Findings included MDMA (106 samples), ketamine (87 samples), cocaine (51 samples), amphetamine (47 samples), methamphetamine (two samples), heroin (two samples) and NPS (nine samples). Two samples were identified as precursors of psychoactive substances. Identification of a non-controlled substance occurred in 38 samples. Output of inconclusive result was recorded from 128 samples tested on-site, from which the applicant allowed us to collect a small portion in 68 cases, for a delayed laboratory analysis by GC-MS or LC-MS/MS. DISCUSSION AND
CONCLUSIONS: Drug checking by Raman spectroscopy proved effective to identify psychoactive drugs including NPS and track the drug distribution in various recreational settings. The field testing activity revealed the presence of several NPS in the nightlife scenario, often in replacement of traditional illicit drugs, thus posing a high overdose risk and a life-threatening situation.
© 2019 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Keywords:  NPS; Raman; drug checking; harm reduction

Mesh:

Substances:

Year:  2019        PMID: 30614092     DOI: 10.1111/dar.12887

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  7 in total

1.  Should NPS be included in workplace drug testing?

Authors:  Alberto Salomone; Joseph J Palamar; Marco Vincenti
Journal:  Drug Test Anal       Date:  2020-01-23       Impact factor: 3.345

Review 2.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

3.  The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.

Authors:  Jennifer J Carroll; Sarah Mackin; Clare Schmidt; Michelle McKenzie; Traci C Green
Journal:  Harm Reduct J       Date:  2022-02-04

4.  A calibration friendly approach to identify drugs of abuse mixtures with a portable near-infrared analyzer.

Authors:  Ruben F Kranenburg; Henk-Jan Ramaker; Sharon Sap; Arian C van Asten
Journal:  Drug Test Anal       Date:  2022-02-09       Impact factor: 3.234

5.  Performance evaluation of handheld Raman spectroscopy for cocaine detection in forensic case samples.

Authors:  Ruben F Kranenburg; Joshka Verduin; Renee de Ridder; Yannick Weesepoel; Martin Alewijn; Marcel Heerschop; Peter H J Keizers; Annette van Esch; Arian C van Asten
Journal:  Drug Test Anal       Date:  2021-01-07       Impact factor: 3.345

Review 6.  Drug checking to detect fentanyl and new psychoactive substances.

Authors:  Joseph J Palamar; Alberto Salomone; Monica J Barratt
Journal:  Curr Opin Psychiatry       Date:  2020-07       Impact factor: 4.787

7.  Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply.

Authors:  Nabarun Dasgupta; Mary C Figgatt
Journal:  Am J Epidemiol       Date:  2022-01-24       Impact factor: 4.897

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.